Protalix BioTherapeutics (PLX) Tops Q1 EPS by 40c, Revenues Beat

Go back to Protalix BioTherapeutics (PLX) Tops Q1 EPS by 40c, Revenues Beat
PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) Delayed: 2.71 +0.03 (1.12%)
Previous Close $2.68    52 Week High $1.11 
Open $2.71    52 Week Low $0.41 
Day High $2.73    P/E N/A 
Day Low $2.70    EPS $-0.29 
Volume 63,043